Elevated serum IL-6 levels predict mortality in approximately 50% of HF patients (11), and high tumor necrosis factor (TNF)-α levels in patients with severe COVID-19 may exacerbate the development of HF (12). The gene discussed is IL6; the disease is COVID-19.